Work

Subgroup analysis of leiomyosarcoma patients from a phase 3, open-label, randomized study of eribulin versus dacarbazine in patients with advanced liposarcoma or leiomyosarcoma

Year: 2017

Type: article

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(17)30581-6

Authors: J.Y. Blay, P. Schöffski, S. Bauer, A. Krarup-Hansen, C. Benson, D. D'Adamo, M. Guo, R. Maki

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2587302386

FWCI: 0.227

Cites:

Cited by: 1

Related to: 10